İsmail YURTSEVER, İbrahim Hakkı KÖKER, Hakan ŞENTÜRK, Nurlan HUSEYNOV, Ömer UYSAL

Prediction of mortality at first admission in COVID-19 pneumonia: A retrospective cohort study

The Coronovirus-19 (COVID-19) pandemic that started in Wuhan, China, at the end of 2019 may cause severe acute respiratory syndrome in some patients. We aimed to investigate the factors that can provide admission mortality prediction in patients with a definite diagnosis of COVID-19. We included patients with radiologically confirmed COVID-19 pneumonia with any significant comorbidities between February 2020-May 2020. We included 129 patients with a mean age of 58 ±15.3 years (range 16-88), 74 (57.4%) men, and of which 27 (21%) died in hospital. Age, aspartate aminotransferase (AST), gamma-glutamyltranspeptidase (GGT), albumin, international normalization ratio (INR), C-reactive protein (CRP), ferritin, d-dimer, and leukocyte levels differed between those who survived and died in the hospital. Multivariable regression showed increased odds of in-hospital death associated with older age (odds ratio 1.09 95% Confidence Interval [CI] (1.021-1.169; p=0.01), and ferritin 1.003 (1.001-1.004; p289 ng/mL had a 100% negative predictive value to differentiate surviving from in-hospital dead patients.

PDF

___

1. Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study Lancet. 2020;395,507-13.
2. Lippi G, Plebani M. Laboratory abnormalities in patients with COVID-2019 infection. Clin Chem Lab Med. 2020;58:1131-4.
3. Bohn MK, Lippi G, Horvath A, et al. Molecular, serological, and biochemical diagnosis and monitoring of COVID-19: IFCC task force evaluation of the latest evidence. Clin Chem Lab Med. 2020 25;58:1037-52.
4. Prokop M, van Everdigen W, van Rees Vellinga T, et al. CO-RADS: A Categorical CT Assesment Scheme for Patients Suspected of Having COVID-19- Definition and Evaluation. Radiology. 2020;296:E97-E104.
5. Rosario C, Zandman-Goddard G, Meyron-Holtz E, et al. The hyperferritinemic Syndrome: macrophage activation syndrome, Still's disease, septic shock, and catastrophic antiphospholipid syndrome. BMC Medicine. 2013;11:185.
6. Crayne CB, Albeituni S, Nichols KE, et al. The immunology of macrophage activation syndrome. Front Immunol. 2019;10:119.
7. Sandler RD, Tattersall RS, Schoemans H, et al. Diagnosis and Management of Secondary HLH/MAS Following HSCT and CAR-T Cell Therapy in Adults; A Review of the Literature and a Survey of Practice Within EBMT Centres on Behalf of the Autoimmune Diseases Working Party (ADWP) and Transplant Complications Working Party (TCWP). Front. Immunol. 2020;11;524.
8. Kappert K, Jahic A, Tauber R. Assessment of serum ferritin as a biomarker in COVID-19: bystander or participant? Insights by comparison with other infectious and non-infectious diseases. Biomarkers. 2020;25:616-25.
9. Ravvelli A, Minoia E, Davi S, et al. Classification criteria for macrophage activation. Annals of the Rheumatic Diseases. 2016;75:481-9.
10. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054-62.
11. Carubbi F, Salvati L, Alunno A, et al. Ferritin is associated with the severity of lung involvement but not with worse prognosis in patients with COVID-19: data from two Italian COVID-19 units. Scien Rep. 2021;11:4863.
12. Tural Onur S, Altın S, Sokucu SN, et al. Could ferritin level be an indicator of COVID-19 disease mortality? J Med Virol. 2021; 93:1672-7.
13. Wu C, Chen X, Cai Y, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Int Med. 2020:180:934.
14. Taneri PE, Gomez-Ochoa SA, Llanaj E, et al. Anemia and iron metabolism in COVID-19: a systematic review and meta-analysis. Europ J of Epidem. 2020:35;763-73.
15. Rutledge AC, Choi YH, Karp I, et al. Biochemistry tests in hospitalized COVID-19 patients: Experience from a Canadian tertiary care centre. Clin Biochem. 2021;19:S0009-9120:00149-1. Online ahead of print.
16. Shah A, Frost JN, Aaron L, et al. Systemic hypoferremia and severity of hypoxemic respiratory failure in COVID-19. Crit Care. 2020;24:320.
17. Li X, Xu S, Yu M, et al. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. J Allergy Clin Immunol. 2020;146:110-8.